Published in J Clin Psychiatry on August 01, 2014
Buprenorphine for Late-Life Treatment Resistant Depression (BUILD) | NCT01071538
Evaluation of opioid modulation in major depressive disorder. Neuropsychopharmacology (2014) 0.92
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators. J Am Chem Soc (2016) 0.84
Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice. Psychopharmacology (Berl) (2014) 0.82
Dynorphin, Dysphoria, and Dependence: the Stress of Addiction. Neuropsychopharmacology (2016) 0.80
Neurobiology of opioid dependence in creating addiction vulnerability. F1000Res (2016) 0.80
The influence of prescription opioid use duration and dose on development of treatment resistant depression. Prev Med (2016) 0.79
Antidepressant-like effects of buprenorphine in rats are strain dependent. Behav Brain Res (2014) 0.79
Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain. J Pain Res (2015) 0.79
Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials. Depress Anxiety (2016) 0.78
Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction. Front Neurosci (2015) 0.78
The New Kid on the Block-Incorporating Buprenorphine into a Medical Toxicology Practice. J Med Toxicol (2016) 0.77
Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice. J Psychopharmacol (2015) 0.77
Applications of magnetic resonance imaging for treatment-resistant late-life depression. Dialogues Clin Neurosci (2015) 0.75
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress. Elife (2017) 0.75
Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors. Neuropsychopharmacology (2016) 0.75
Self-reported Sleep Improvement in Buprenorphine MAT (Medication Assisted Treatment) Population. Austin J Drug Abuse Addict (2016) 0.75
Major Depressive Disorder and Kappa Opioid Receptor Antagonists. Transl Perioper Pain Med (2016) 0.75
Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Rev Neurother (2017) 0.75
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression. Sci Rep (2016) 0.75
The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plast (2017) 0.75
The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice. Psychopharmacology (Berl) (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol (1988) 60.71
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78
A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40
Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol (1979) 8.44
The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl (1987) 4.49
The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs (2003) 3.91
Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther (2003) 3.48
The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry (2004) 3.17
Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients. Behav Res Ther (1997) 2.70
Suicide ideation at its worst point: a predictor of eventual suicide in psychiatric outpatients. Suicide Life Threat Behav (1999) 2.69
Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. Clin Neuropsychol (1999) 2.65
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel. J Clin Psychiatry (1997) 2.46
Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract (2006) 1.89
Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care (2010) 1.82
Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry (2007) 1.78
Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry (2006) 1.73
Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry (2007) 1.68
Clinical antidepressant activity of cyclazocine--a narcotic antagonist. Clin Pharmacol Ther (1970) 1.62
Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry (2007) 1.60
Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry (2004) 1.52
Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. J Am Geriatr Soc (2007) 1.50
Depression, IV: STAR*D treatment trial for depression. Am J Psychiatry (2003) 1.48
Buprenorphine treatment of refractory depression. J Clin Psychopharmacol (1995) 1.37
A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. J Clin Psychiatry (2003) 1.21
Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. J Pharmacol Exp Ther (2002) 1.05
Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial. J Clin Psychopharmacol (2008) 1.04
Psychotherapeutic benefits of opioid agonist therapy. J Addict Dis (2008) 1.04
Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies. Drug Saf (2010) 0.97
Depressive symptoms during buprenorphine treatment of opioid abusers. J Subst Abuse Treat (1990) 0.95
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. Int J Neuropsychopharmacol (2006) 0.94
Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain. Clin J Pain (2002) 0.94
Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin. Br J Pharmacol (2000) 0.94
Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients. Anesth Analg (2007) 0.87
beta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients. Arch Gen Psychiatry (1980) 0.87
Detecting age differences in resistance to perceptual and motor interference. Exp Aging Res (2011) 0.86
Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates. BMC Clin Pharmacol (2011) 0.83
Monoamine oxidase inhibitor hypertensive crisis headache and orthostatic hypotension. J Clin Psychopharmacol (1993) 0.82
Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression. J Clin Psychopharmacol (2006) 0.77
Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA (2004) 8.83
Maintenance treatment of major depression in old age. N Engl J Med (2006) 7.61
Treatment of complicated grief: a randomized controlled trial. JAMA (2005) 5.15
The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimers Dement (2006) 5.05
Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med (2003) 4.30
Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA (2009) 4.06
Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med (2011) 3.73
Recruiting and retaining future generations of physician scientists in mental health. Arch Gen Psychiatry (2002) 3.69
Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med (2006) 3.27
The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry (2004) 3.17
Confronting depression and suicide in physicians: a consensus statement. JAMA (2003) 3.06
The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry (2013) 3.06
Preventing depression: a global priority. JAMA (2012) 2.92
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial. JAMA (2009) 2.60
Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am J Psychiatry (2009) 2.56
Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med (2009) 2.40
Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci (2008) 2.30
Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29
Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry (2013) 2.23
Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med (2006) 2.22
The course of functional decline in older people with persistently elevated depressive symptoms: longitudinal findings from the Cardiovascular Health Study. J Am Geriatr Soc (2005) 2.20
Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res (2003) 2.14
A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res (2006) 2.08
Depression, antidepressants, and bone health in older adults: a systematic review. J Am Geriatr Soc (2014) 2.08
Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. Arch Gen Psychiatry (2009) 2.08
A waterborne outbreak of gastroenteritis with multiple etiologies among resort island visitors and residents: Ohio, 2004. Clin Infect Dis (2007) 2.07
A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry (2007) 2.04
Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry (2005) 2.04
Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry (2009) 2.01
Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care. BMJ (2013) 1.91
Preventing the onset of major depressive disorder: a meta-analytic review of psychological interventions. Int J Epidemiol (2014) 1.85
Onset of depression in elderly persons after hip fracture: implications for prevention and early intervention of late-life depression. J Am Geriatr Soc (2007) 1.85
Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control (2010) 1.82
A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc (2008) 1.82
Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry (2006) 1.77
Age-related decline in white matter tract integrity and cognitive performance: a DTI tractography and structural equation modeling study. Neurobiol Aging (2010) 1.77
Post stroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry (2002) 1.76
Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry (2005) 1.76
The relationship between pain and mental flexibility in older adult pain clinic patients. Pain Med (2006) 1.75
Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75
Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry (2006) 1.73
Interference screw versus suture anchor fixation for subpectoral tenodesis of the proximal biceps tendon: a cadaveric study. Arthroscopy (2008) 1.71
Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry (2002) 1.70
Effect of rehabilitation site on functional recovery after hip fracture. Arch Phys Med Rehabil (2005) 1.69
Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry (2007) 1.68
Mental health treatment seeking among older adults with depression: the impact of stigma and race. Am J Geriatr Psychiatry (2010) 1.67
Cognitive impairment in late-life generalized anxiety disorder. Am J Geriatr Psychiatry (2007) 1.67
A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiatry (2005) 1.65
Can performance on daily activities discriminate between older adults with normal cognitive function and those with mild cognitive impairment? J Am Geriatr Soc (2014) 1.65
Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT (2013) 1.62
Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology. Arch Gen Psychiatry (2012) 1.62
Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry (2003) 1.60
Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry (2007) 1.60
The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief. Compr Psychiatry (2007) 1.59
Perchlorate in drinking water during pregnancy and neonatal thyroid hormone levels in California. J Occup Environ Med (2010) 1.59
Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. Am J Psychiatry (2004) 1.59
Rates and predictors of mortality in an aging, rural, community-based cohort: the role of depression. Arch Gen Psychiatry (2002) 1.57
Functional bracing after anterior cruciate ligament reconstruction: a prospective, randomized, multicenter study. Am J Sports Med (2004) 1.54
Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry (2009) 1.54